AM
AMI Leaders What is the objective of the AMI Leaders programme?
Produced and funded by Allergan. ND/0247/2019 | Date of preparation: July 2019
AMI Leaders
Learn a new language and injection methodology with an introduction to the MD Codes™ and their clinical applications
AMI Leaders
AM
AMI Leaders
What is the purpose of the MD Codes™?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders
To support the technical development of injectors
AMI Leaders
AM
AMI Leaders
What are the MD Codes™?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders A specific language in facial aesthetics to raise awareness that each aesthetic facial unit (e.g. cheek, chin, lips) comprises subunits that must be respected during injection
AMI Leaders
AM
AMI Leaders
What does FACT stand for?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders
Finance Assessment Communication Technique AMI Leaders
AM
AMI Leaders
F is for Finance
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders The MD Codes™ help patients to see more clearly the different components of their treatment plan and make informed decisions
AMI Leaders
AM
AMI Leaders
A is for Assessment
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders By understanding how facial units and subunits impact each other, correct diagnosis can be made and appropriate treatments identified
AMI Leaders
AM
AMI Leaders
C is for Communication
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders Patient wants and patient needs are often misaligned The MD Codes™ can help educate patients on their treatment needs
AMI Leaders
AM
AMI Leaders
T is for Technique
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders The MD Codes™ provide in-depth guidance on appropriate injection technique
AMI Leaders
AM
AMI Leaders
What is the concept of patient wants versus patient needs?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders Patient wants (their treatment requests) and patient needs (their clinical diagnosis) often differ An expert injector should educate their patient on the treatment that will aim to provide the best clinical outcome
AMI Leaders
AM
AMI Leaders
What is the concept of Foundation– Contour–Refinement?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
AMI Leaders The recommended order in which treatment with the MD Codes™ should be considered, to revitalise the face in an architectural mode
AMI Leaders
BUILD FOUNDATION Midface
Ck
Ck
Produced and funded b
Question goes here...
For illustrative purposes only Produced and funded by Allergan. Image Š owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019
AM
AMI Leaders As with building a house, facial aesthetic treatment should begin with the foundation – creating structure to support the overlying tissues
AMI Leaders
CREATE CONTOUR Upper and lower face
T
T
Question goes here... Jw
Jw C For illustrative purposes only
Produced and funded by Allergan. Image Š owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019
AM
AMI Leaders
Once the foundation is in place, treatment should focus on shaping the contours of the upper and/or lower face
AMI Leaders
FOCUS ON REFINEMENT
Upper and lower face F
E
E
Tt
Tt
O
O
NL
NL
Question goes here... Lp
M
M
For illustrative purposes only Produced and funded by Allergan. Image © owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019
AM
AMI Leaders Any remaining refinements, such as lines or folds, should be addressed after the first two stages have been completed, as their appearance may have already improved
AMI Leaders
F2
F1
F3
F1
G1
F2
G1 G2
Tt2
Tt3 Tt1
Lp7
Lp
Lp8
Lp 2
3
Lp
Lp 6
Lp11
Lp4
Lp1
Lp1 Lp5
3
Lp11
Lp5
C1
C6
C6
C3
C5
C3 C4
C5
C2
For illustrative purposes only Produced and funded by Allergan. Image © owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019
T2
E2 E3 E1
T1
O3
O1
O2
Ck1
Ck2
Ck3
Jw2 Ck4 NL 1
Ck5 2
NL 3
NL
Jw1
M1 M2
3 Jw
M3
Jw5
Jw4
For illustrative purposes only Produced and funded by Allergan. Image Š owned by Allergan Funded byINT/0712/2018ab Allergan | INT/0712/2018ab | Date of preparation: March 2019 | Date of preparation: March 2019
Starting the journey
Starting the journey
Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019
P
1
AM
P A T T E R N S .
P A T T E R N S .
1
P
AMI Leaders
Systematise the basics There are patterns and sequences to facial revitalisation
AMI Leaders
V
AMI Visionary What are the objectives of the AMI Visionary programme?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Visionary Explore a new approach to patient consultation with the emotional attributes Learn how to treat key facial signs with the MD Codes™ Equations
Visionary
V
AMI Visionary What is the purpose of the emotional attributes (patient feels)?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Visionary To help injectors understand patients’ real motivations for seeking treatment and deliver an outcome that meets their true expectations
Visionary
V
AMI Visionary
What are the positive emotional attributes?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Visionary
THE DREAM
The overall facial messages patients often aspire to: Look more attractive Look younger Look slimmer/more contoured Look more feminine/masculine
Visionary
V
AMI Visionary
What are the negative emotional attributes?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Visionary THE REALITY The overall facial messages that detract from facial attractiveness and youthfulness Look less tired Look less sad Look less saggy
Visionary
Look less angry
V
AMI Visionary
What does ‘clean the house first’ mean?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Visionary
To achieve the positive emotional attributes, negative messages should first be reduced or erased
Visionary
V
AMI Visionary
What are key facial signs?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Visionary A suboptimal feature or ageing sign (e.g. a saggy cheek) that is characteristic of a negative emotional attribute
Visionary
V
AMI Visionary
What are the MD Codesâ„¢ Equations?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Visionary The translation of the key facial signs into the MD Codes™ A step towards creating the MD Codes™ Formulas
Visionary
Shifting mindset
Shifting mindset
Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019
P
2
V
P A R A D I G M .
P A R A D I G M .
2
P
Visionary Place a value on expertise Patients expect more than what they ask for
Visionary
D
AMI Distinction What are the objectives of the AMI Distinction programme?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Distinction Bring strategy to treatment planning with the MD Codes™ Formulas Learn a system to organise the facial assessment process with MD ASA™
Distinction
D
AMI Distinction
What does MD ASA™ stand for and what is its purpose?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Distinction Multi-Dimensional Aesthetic Scan Assessment A system of aesthetic hierarchy to organise the patient assessment process and train the brain to decipher complex and unveiled signs of the face
Distinction
D
AMI Distinction
What is the aesthetic hierarchy?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Distinction
The five pillars of systematic facial assessment, ranging from full face (H1) to distractions (H5)
Distinction
D
AMI Distinction
What are the MD Codes™ Formulas?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Distinction A sequence of MD Codes™ Equations that, when grouped together, form a holistic treatment plan that aims to address a specific emotional attribute
Distinction
D
AMI Distinction
What is the MD Codes™ Formulas Treatment Plan?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Th ses sh inj pa be pe
Distinction A multi-session treatment planning strategy that uses volume estimations to deliver the MD Codes™ Formulas, tailored to individual patient needs
Distinction This approach generally recommends that each session is built around four syringes; however, this should be based on the clinical judgement of the injector. This volume may not be suitable for all patients for all sessions. Clinical judgment should be used to determine the total volume appropriate per session, based on individual patient needs.
MD ASA™ aesthetic hierarchy
Distinction
Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019
H1: Full face: Analysis Patient feels: Emotional attributes
H2: Facial thirds and neck: Analysis Patient presents: Symmetry and proportion
Distinction
H3: Periorbital and perioral: Analysis Patient expresses: Animation
H4: Facial units: Analysis Patient needs: Key facial units or areas
H5: Facial subunits: Analysis Patient wants: Distractions Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Establishing priorities
Establishing priorities
Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019
P
3
D
P L A N N I N G .
P L A N N I N G .
3
P
Distinction Plan according to outcomes Patients expect more than what they ask for
Distinction
Ex AMI Expression What are the objectives of the AMI Expression programme?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Expression Explore the principles of dynamic ageing and dynamic beauty with the introduction of the MD DYNA Codes™ and dynamic MD ASA™
Expression
Ex AMI Expression
What is dynamic beauty?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
1. d
Expression
Beauty is not only related to the face at rest; it requires co-ordination of multiple mimetic muscles1 Facial treatments should aim to produce a balanced and harmonious outcome both at rest and on animation
Expression
1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.
Ex AMI Expression
What is dynamic ageing?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
1. d
Expression Dynamic ageing is the muscle imbalance that happens during the ageing process, caused by loss of structural support and the gravitational impact on facial areas1
Expression 1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.
Ex AMI Expression
What is the concept of patient expresses?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Expression There may be ageing signs and/or downgrading features that only appear on animation and these should be identified during facial assessment to avoid unnatural results
Expression
Ex AMI Expression
What is the principle of chemical myomodulation?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
*Bo and Ind req info
1. d
Expression It is the chemical* approach to reduce dynamic lines through intramuscular injection1
Expression *Botulinum toxin type A indications may vary by country and responses to treatment may differ between patients. Indication requirements will be dependent on patient requirements. Please refer to your local prescribing information for full product information and indications. 1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.
Ex AMI Expression
What is the principle of mechanical myomodulation?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
1. d
Expression It is the principle that mimetic muscles can be affected by the precise placement of hyaluronic acid filler below or above the fibres to either facilitate or reduce muscle action, respectively1
Expression 1. de Maio M. Aesthetic Plast Surg 2018; 42:798–814.
Ex AMI Expression
What are the MD DYNA Codesâ„¢?
Produced and funded by Allergan. INT/0712/2018ab | Date of preparation: March 2019
Expression Precise injection techniques to indirectly modulate muscle activity and help injectors deliver natural facial expression and aesthetic rehabilitation of the face
Expression
Periorbital muscles1
Expression F
F
C
C P
OOc
OOc
Produced and funded by Allergan. Image Š owned by Allergan INT/0712/2018ab | Date of preparation: March 2019
Perioral muscles1
Expression N
* LAO
N
DSN
LAN
LLS
ZMi R
ZMj
OO
OO
DAO
DLI
* Deep to upper lip levators
PL
M
B*
Image © owned by Allergan | 1. Gray H. The muscles and fasciae.
In: Pick TP, Howden R, eds. Anatomy, Descriptive and Surgical. 1st ed. Running Press, 1974. p. 306–15. ISBN: 978-0-7020-5230-9.
Anticipating challenges
Anticipating challenges
Produced and funded by Allergan. Image Š owned by Allergan and Dr Mauricio de Maio | INT/0712/2018ab | Date of preparation: March 2019
P
4
Ex P R E D I C T I O N .
P R E D I C T I O N .
4
P
Expression Learn from facial animation Dynamic ageing can predict static ageing
Expression